RT Journal Article
SR Electronic
T1 How to coordinate vaccination and social distancing to mitigate SARS-CoV-2 outbreaks
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.22.20248707
DO 10.1101/2020.12.22.20248707
A1 Sara Grundel
A1 Stefan Heyder
A1 Thomas Hotz
A1 Tobias K. S. Ritschel
A1 Philipp Sauerteig
A1 Karl Worthmann
YR 2021
UL http://medrxiv.org/content/early/2021/04/21/2020.12.22.20248707.abstract
AB Most countries have started vaccinating people against COVID-19. However, due to limited production capacities and logistical challenges it will take months/years until herd immunity is achieved. Therefore, vaccination and social distancing have to be coordinated. In this paper, we provide some insight on this topic using optimization-based control on an age-differentiated compartmental model. For real-life decision making, we investigate the impact of the planning horizon on the optimal vaccination/social distancing strategy. We find that in order to reduce social distancing in the long run, without overburdening the healthcare system, it is essential to vaccinate the people with the highest contact rates first. That is also the case if the objective is to minimize fatalities provided that the social distancing measures are sufficiently strict. However, for short-term planning it is optimal to focus on the high-risk group.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Federal Ministry of Education and Research (BMBF; grants 05M18EVA and 05M18SIA)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There were no IRB approvals necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available in the manuscript and the references therein.